Procyon (PCYN) Stock Overview
Manufactures and markets wound and skin care products primarily in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PCYN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Procyon Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.19 |
| 52 Week High | US$0.19 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -24.04% |
| 5 Year Change | -71.08% |
| Change since IPO | -87.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| PCYN | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -5.4% | -2.3% |
| 1Y | n/a | -8.5% | 20.4% |
Return vs Industry: Insufficient data to determine how PCYN performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how PCYN performed against the US Market.
Price Volatility
| PCYN volatility | |
|---|---|
| PCYN Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.7% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: PCYN's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PCYN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 20 | Justice Anderson | procyoncorp.com |
Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matrix, collagen powder, foam, hydrogel, and rolled gauze wound care kits under the AMERX brand. The company also offers AMERIGEL hand sanitizer; EXTREMIT-EASE compression garment products; Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; calcium alginate, foam, and gauze dressings; retention tapes; and helix collagen gel.
Procyon Corporation Fundamentals Summary
| PCYN fundamental statistics | |
|---|---|
| Market cap | US$1.54m |
| Earnings (TTM) | -US$312.96k |
| Revenue (TTM) | US$4.98m |
Is PCYN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCYN income statement (TTM) | |
|---|---|
| Revenue | US$4.98m |
| Cost of Revenue | US$1.09m |
| Gross Profit | US$3.89m |
| Other Expenses | US$4.20m |
| Earnings | -US$312.96k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PCYN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/12 09:58 |
| End of Day Share Price | 2026/02/10 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Procyon Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.